Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Justification And Evaluation of Baricitinib Plus Corticosteroids Versus corticosteroiDs Alone in pOlymyalgia RhEumatica - JADORE-BARI Study

NCT07279688 is registered in ClinicalTrials.gov with University Hospital, Brest as lead sponsor.

NCT NCT07279688
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07279688 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Justification And Evaluation of Baricitinib Plus Corticosteroids Versus corticosteroiDs Alone in pOlymyalgia RhEumatica - JADORE-BARI Study
Lead sponsor
University Hospital, Brest
Phase
Phase 3
Overall status
Recruiting
Start date
December 18, 2025
Completion date
June 30, 2029
Enrollment
140 (estimated)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

polymyalgia rheumatica (pmr)